Skip to content

Effect of Low-pressure Pneumoperitoneum on Pain and Inflammation Post Laparoscopic Cholecystectomy

Effect of Low-pressure Pneumoperitoneum on Pain and Inflammation Post Laparoscopic Cholecystectomy: A Randomized, Double-blinded, Controlled, Clinical Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04779515
Enrollment
100
Registered
2021-03-03
Start date
2020-01-20
Completion date
2021-01-22
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation, Pain, Pneumoperitoneum

Keywords

low-pressure pneumoperitoneum, lap chole

Brief summary

The purpose of this study is to assess the effect of low-pressure pneumoperitoneum on post operative pain and inflammation in patients undergoing elective laparoscopic cholecystectomy by comparing it to standard practice.

Detailed description

After obtaining informed consent from eligible study participants. patients were randomized into one of two masked groups, labelled red and green. The red-label group was operated at standard-pressure pneumoperitoneum, while the green-label group was operated at low-pressure pneumoperitoneum. Baseline blood samples were obtained pre-operatively for ten inflammatory markers, patients' demographics and intra-operative details collected, then post-operative pain and change in inflammatory markers were followed.

Interventions

insufflation of the abdomen for creation of pneumoperitoneum, pressure set points between 8 to 10 mm Hg

insufflation of the abdomen for creation of pneumoperitoneum, pressure set points between 12 to 14 mm Hg

Sponsors

University of Jordan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

none of the participants knew at which pressure they will be operated on, nor the physicians who followed participants at floor or those analyzing blood samples, not the assigned physician to collect data, nor the personnel doing the analysis. only the operating surgeon and circulating nurse were aware of the meaning of the participant assigned label at time of operation. The masking was revealed post completion of analysis.

Intervention model description

participants were divided into two masked groups, labelled red and green; those operated at low-pressure pneumoperitoneum (green-label) and those operated at standard-pressure pneumoperitoneum (red-label).

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Elective admission for laparoscopic cholecystectomy

Exclusion criteria

* Current or previous diagnosis of acute cholecystitis confirmed by ultrasound * previous GI surgeries, except bariatric and anti-reflux surgeries * Currently on immunosuppressant agents * Pregnancy * Breastfeeding * Currently diagnosed with drug addiction * American Society of Anesthesiologists (ASA) score 3 and more

Design outcomes

Primary

MeasureTime frameDescription
change from baseline in TNF level at 24hr post opbaseline and 24 hours post-opcalculate the rise in tumor necrosis factor alpha level as inflammatory marker post-op in pg/mL change = (post-op TNF) - (baseline TNF)
change from baseline in IL-17 level at 24hr post opbaseline and 24 hours post-opcalculate the rise in interleukin 17 level as inflammatory marker post-op in pg/mL change = (post-op IL-17) - (baseline IL-17)
change from baseline in IL-1 level at 24hr post opbaseline and 24 hours post-opcalculate the rise in interleukin 1 level as inflammatory marker post-op in pg/mL change = (post-op IL-1) - (baseline IL-1)
change from baseline in pain on the 11-point short pain scale (SPS-11) at hour 12 post-opbaseline and 12 hours post-opthe SPS-11 is a validated, self-reported numeric instrument assessing pain intensity, ranging from 0 to 10; where 0 is no pain, and 10 is the worst pain felt ever. change = (pain score at 12-hr post-op) - (baseline pain score assessed at 6-hr post-op)
change from baseline in pain on the 11-point short pain scale (SPS-11) at hour 24 post-opbaseline and 24 hours post-opthe SPS-11 is a validated, self-reported numeric instrument assessing pain intensity, ranging from 0 to 10; where 0 is no pain, and 10 is the worst pain felt ever. change = (pain score at 24-hr post-op) - (baseline pain score assessed at 6-hr post-op)
change from baseline in pain on the 11-point short pain scale (SPS-11) at day 7 post-opbaseline and 7 days post-opthe SPS-11 is a validated, self-reported numeric instrument assessing pain intensity, ranging from 0 to 10; where 0 is no pain, and 10 is the worst pain felt ever. change = (pain score at post-op day 7) - (baseline pain score assessed at 6-hr post-op)
change from baseline in WBC count at 24hr post opbaseline and 24 hours post-opcalculate the rise in white blood cycles count as inflammatory marker post-op in 1000 cells per cubic millimeter of blood. change = (post-op WBC count) - (baseline WBC count)
change from baseline in Plt count at 24hr post opbaseline and 24 hours post-opcalculate the rise in platelets count as inflammatory marker post-op in × 10\^9/L of blood change = (post-op Plt count) - (baseline Plt count)
change from baseline in ESR value at 24hr post opbaseline and 24 hours post-opcalculate the rise in erythrocyte sedimentation rate value as inflammatory marker post-op in millimeters per hour. change = (post-op ESR) - (baseline ESR)
change from baseline in CRP level at 24hr post opbaseline and 24 hours post-opcalculate the rise in C reactive protein level as inflammatory marker post-op in mg/L change = (post-op CRP) - (baseline CRP)
change from baseline in Alb level at 24hr post opbaseline and 24 hours post-opcalculate the drop in albumin level as inflammatory marker post-op in g/dL change = (baseline Alb) - (post-op baseline Alb)
change from baseline in cortisol level at 4hr post opbaseline and 4 hours post-opcalculate the rise in cortisol level as inflammatory marker post-op in nmol/L change = (post-op cortisol ) - (baseline cortisol )
change from baseline in IL-6 level at 24hr post opbaseline and 24 hours post-opcalculate the rise in interleukin 6 level as inflammatory marker post-op in pg/mL change = (post-op IL-6) - (baseline IL-6)

Secondary

MeasureTime frameDescription
Difference in surgery time among two groupsthrough study completion, an average of 1 yearassessing difference in insufflation time calculated in minutes between low and standard pressure pneumoperitoneum groups. insufflation time was calculated from time of creation of pneumoperitoneum to deflation of the abdomen. Difference assessed by calculating average between groups
Difference in surgery difficulty level among two groupsthrough study completion, an average of 1 yearassessing level of surgery difficulty between low and standard pressure pneumoperitoneum groups. Difficulty was self reported by operating surgeon as easy (score=1), moderate (score=2), or difficult (score=3). Difference assessed by calculating average between groups

Countries

Jordan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026